ClinicalTrials.Veeva

Menu

Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants (EXODENT)

A

Assistance Publique - Hôpitaux de Paris

Status

Unknown

Conditions

Dentin Anomalies
Dentinogenesis Imperfecta
Amelogenesis Imperfecta

Treatments

Biological: Blood sample

Study type

Interventional

Funder types

Other

Identifiers

NCT03810859
2018-A01250-55 (Other Identifier)
K180404J

Details and patient eligibility

About

ExoDent specifically aims to discover new genes and new mutations causing isolated amelogenesis imperfecta (AI) and dentinogenesis imperfecta (DI) and other dentin anomalies. The key point for clinicians is to distinguish between non syndromic and syndromic disorders in order to improve patients guidance and counseling. To do so, two targeted NGS panel have been designed, one searching for isolated AI and the other for DI. After 18 months, some families remain without any positive results. ExoDent project proposes those negative patients a Whole Exome Sequencing (WES) approach to deeper explore their genetic background.

Enrollment

14 patients

Sex

All

Ages

4+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of amelogenesis imperfecta or dentinogenesis imerfecta or other dentin anomaly with no other signs or symptoms ( familial or isolated)
  • negative results after targeted NGS strategy for molecular diagnosis

Exclusion criteria

  • absence of positive clinical diagnosis
  • Diagnosis of syndromic disease

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

14 participants in 1 patient group

All patients
Experimental group
Description:
Blood sample
Treatment:
Biological: Blood sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems